Who
Laura Kay Matherly
Director
Company insider
Files Form 4 as: Director, Natural Alternatives International.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Apr 2020
- Last trade
- 6 Mar 2026
- Last filed
- 10 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 8 Mar 2024filed 15 Mar 2024 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 7 Mar 2023filed 9 Mar 2023 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —7,000 at $0.00 | filing |
| 4 Mar 2022filed 8 Mar 2022 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —7,000 at $0.00 | filing |
| 15 Mar 2021filed 18 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 17 Apr 2020filed 27 Apr 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code J | —15,000 at $0.00 | filing |
| 1 Apr 2020filed 2 Apr 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.